Discovery of Novel Molecular Mechanisms Underlying the Pathophysiology of Uterine Fibroids and Associated Heavy Menstrual Bleeding.

被引：0

作者：

Wang, Chen-Yi ^{[1
]}

Maritati, Marina ^{[1
]}

Brien, Darragh P. O. Prime ^{[1
]}

Subramaniam, Kavita S. ^{[1
]}

Cribbs, Adam ^{[1
]}

Malzahn, Jessica ^{[1
]}

Zollner, Thomas M. ^{[2
]}

De Leo, Bianca ^{[2
]}

Obendorf, Maik ^{[2
]}

Mueller, Joerg ^{[2
]}

Fritsch, Martin ^{[2
]}

Kessler, Benedikt M. ^{[1
]}

Zondervan, Krina T. ^{[1
]}

Harris, Adrian ^{[1
]}

Becker, Christian M. ^{[1
]}

Oppermann, Udo ^{[1
]}

Philpott, Martin ^{[1
]}

机构：

[1] Univ Oxford, Oxford, England

[2] Bayer AG, Berlin, Germany

来源：

REPRODUCTIVE SCIENCES | 2020年 / 27卷 / SUPPL 1期

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

S-032

引用

页码：301A / 301A

页数：1

共 50 条

[21] Linzagolix provides rapid, significant reduction of heavy menstrual bleeding in women with uterine fibroids
Olejek, A.
Ciebiera, M.
Skrzypulec-Plinta, V.
Boolell, M.
Bestel, E.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 293 : 300 - 300
[22] Endometrial Evaluation in Elagolix-Treated Women With Uterine Fibroids and Heavy Menstrual Bleeding
Carr, Bruce R.
Bradley, Linda D.
Owens, Charlotte D.
Gao, Jinging
Chwalisz, Kristof
Simon, James A.
OBSTETRICS AND GYNECOLOGY, 2018, 131 : 82S - 83S
[23] State Level Treatment Differences in Heavy Menstrual Bleeding and Uterine Fibroids: Claims Analysis
Wang, Alice
Wang, Siting
Vora, Jamie
Diamond, Michael
OBSTETRICS AND GYNECOLOGY, 2020, 135 : 27S - 28S
[24] Oriahnn: New Drug Approved for Treating Heavy Menstrual Bleeding in Women With Uterine Fibroids
Lynch, Sarah E.
Mayer, Danielle C.
ANNALS OF PHARMACOTHERAPY, 2022, 56 (01) : 93 - 101
[25] MEASURING PATIENT-REPORTED OUTCOMES IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS: THE BLEEDING AND PELVIC DISCOMFORT SCALE.
Li, Juliet
Kang, Jennifer B.
Hunsche, Elke
Hudgens, Stacie
FERTILITY AND STERILITY, 2019, 112 (03) : E344 - E344
[26] Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis
Hoffman, PJ
Milliken, DB
Gregg, LC
Davis, RR
Gregg, JP
FERTILITY AND STERILITY, 2004, 82 (03) : 639 - 649
[27] Informing Patient Selection for Elagolix Treatment of Heavy Menstrual Bleeding Associated With Fibroids
Al-Hendy, Ayman
Simon, James A.
Bradley, Linda D.
Owens, Charlotte
Wang, Hui
Barnhart, Kurt
OBSTETRICS AND GYNECOLOGY, 2020, 135 : 24S - 24S
[28] The history and use of the progesterone receptor modulator ulipristal acetate for heavy menstrual bleeding with uterine fibroids
Bouchard, Philippe
Chabbert-Buffet, Nathalie
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 40 : 105 - 110
[29] Efficacy and Safety of Elagolix 150 mg QD in Women With Uterine Fibroids and Heavy Menstrual Bleeding
Kroll, Robin
Poindexter, Alfred
Ng, Juki
Li, Hong
Snabes, Michael
OBSTETRICS AND GYNECOLOGY, 2022, 139 : 26S - 26S
[30] Elagolix Alone and With Add-Back Decreases Heavy Menstrual Bleeding in Women With Uterine Fibroids
Stewart, Elizabeth
Owens, Charlotte
Duan, W. Rachel
Gao, Jingjing
Chwalisz, Kristof
Simon, James A.
OBSTETRICS AND GYNECOLOGY, 2017, 129 : 87S - 88S

← 1 2 3 4 5 →